TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

LORATADINE AND PSEUDOEPHEDRINE SULFATE

LORATADINE
Approved 2003-01-30
Jump to: Indications Approvals Trials Competitors Safety Patents
6
Indications
--
Phase 3 Trials
23
Years on Market

Details

Status
Discontinued
First Approved
2003-01-30
Routes
ORAL
Dosage Forms
TABLET, EXTENDED RELEASE

Companies

HERITAGE PHARMA Sun Pharma PERRIGO PHARMA INTL BIONPHARMA P AND L
Active Ingredient: LORATADINE , PSEUDOEPHEDRINE SULFATE

LORATADINE AND PSEUDOEPHEDRINE SULFATE Approval History

Loading approval history...

What LORATADINE AND PSEUDOEPHEDRINE SULFATE Treats

6 FDA approvals

Originally approved for its first indication in 2003 . Covers 6 distinct patient populations.

  • Other (6)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

LORATADINE AND PSEUDOEPHEDRINE SULFATE FDA Label Details

Pro

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: ANDA076208 → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.